Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

NCT01523431 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

583

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Irinotecan Injection [Camptosar]
DRUG: 5-fluorouracil
DRUG: Leucovorin

Sponsor

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences